Search Results

Filter
  • 1-10 of  695 results for ""Oncolytic Viruses""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Effects of oncolytic viruses and viral vectors on immunity in glioblastoma.

  • Authors : Liu P; Departments of Neurosurgery, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100730, China.; Wang Y

Subjects: Brain Neoplasms*/Brain Neoplasms*/Brain Neoplasms*/therapy ; Glioblastoma*/Glioblastoma*/Glioblastoma*/genetics ; Glioblastoma*/Glioblastoma*/Glioblastoma*/therapy

  • Source: Gene therapy [Gene Ther] 2022 Apr; Vol. 29 (3-4), pp. 115-126. Date of Electronic Publication: 2020 Nov 15.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Optimization of oncolytic effect of Newcastle disease virus Clone30 by selecting sensitive tumor host and constructing more oncolytic viruses.

  • Authors : Liu T; College of Life Science, Northeast Agricultural University, Harbin, 150030, China.; Zhang Y

Subjects: Neoplasms* ; Oncolytic Virotherapy* ; Oncolytic Viruses*/Oncolytic Viruses*/Oncolytic Viruses*/genetics

  • Source: Gene therapy [Gene Ther] 2021 Dec; Vol. 28 (12), pp. 697-717. Date of Electronic Publication: 2020 May 14.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Oncolytic Newcastle disease virus expressing the co-stimulator OX40L as immunopotentiator for colorectal cancer therapy.

  • Authors : Tian L; College of Life Science, Northeast Agricultural University, Harbin, China.; Liu T

Subjects: Oncolytic Viruses*/Oncolytic Viruses*/Oncolytic Viruses*/genetics ; Colorectal Neoplasms*/Colorectal Neoplasms*/Colorectal Neoplasms*/therapy; Animals

  • Source: Gene therapy [Gene Ther] 2023 Feb; Vol. 30 (1-2), pp. 64-74. Date of Electronic Publication: 2021 Oct 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Conditional replication of oncolytic viruses based on detection of oncogenic mRNA.

  • Authors : Renteln M; Integrative Molecular Genetics and Biochemistry, University of Southern California, Baylor College of Medicine, Altadena, CA, USA.

Subjects: Biosensing Techniques* ; Oncogenes* ; Virus Replication*

  • Source: Gene therapy [Gene Ther] 2018 Jan; Vol. 25 (1), pp. 1-3. Date of Electronic Publication: 2018 Jan 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Prime-boost using separate oncolytic viruses in combination with checkpoint blockade improves anti-tumour therapy.

  • Authors : Ilett E; Department of Molecular Medicine, Mayo Clinic, Rochester, MN, USA.; Leeds Institute of Cancer and Pathology, St James' University Hospital, Leeds, UK.

Subjects: Cell Cycle Checkpoints*; Immunotherapy/Immunotherapy/Immunotherapy/*methods ; Melanoma/Melanoma/Melanoma/*therapy

  • Source: Gene therapy [Gene Ther] 2017 Jan; Vol. 24 (1), pp. 21-30. Date of Electronic Publication: 2016 Oct 25.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Antitumor effects of IL-12 and GM-CSF co-expressed in an engineered oncolytic HSV-1.

  • Authors : Kim KJ; Laboratory of Gene Therapy, Department of Microbiology, CHA Bundang Medical Center, CHA University, Seongnam, Korea.; Graduate School of the Department of Biomedical Science, CHA University, Seongnam, Korea.

Subjects: Herpesvirus 1, Human*/Herpesvirus 1, Human*/Herpesvirus 1, Human*/genetics ; Oncolytic Viruses*/Oncolytic Viruses*/Oncolytic Viruses*/genetics; Animals

  • Source: Gene therapy [Gene Ther] 2021 Apr; Vol. 28 (3-4), pp. 186-198. Date of Electronic Publication: 2020 Nov 04.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Using clinically approved cyclophosphamide regimens to control the humoral immune response to oncolytic viruses.

  • Authors : Peng KW; Department of Molecular Medicine, Mayo Clinic, Rochester, MN 55905, USA.; Myers R

Subjects: Cyclophosphamide/Cyclophosphamide/Cyclophosphamide/*pharmacology ; Immunity, Humoral/Immunity, Humoral/Immunity, Humoral/*drug effects ; Oncolytic Virotherapy/Oncolytic Virotherapy/Oncolytic Virotherapy/*methods

  • Source: Gene therapy [Gene Ther] 2013 Mar; Vol. 20 (3), pp. 255-61. Date of Electronic Publication: 2012 Apr 05.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses.

  • Authors : Sobol PT; Departments of Biochemistry and Biomedical Sciences, McMaster University, Hamilton, Ontario, Canada.; Hummel JL

Subjects: Interferon-alpha/Interferon-alpha/Interferon-alpha/*pharmacology ; Neoplasms/Neoplasms/Neoplasms/*metabolism ; Nuclear Proteins/Nuclear Proteins/Nuclear Proteins/*metabolism

  • Source: Gene therapy [Gene Ther] 2009 Sep; Vol. 16 (9), pp. 1077-87. Date of Electronic Publication: 2009 May 28.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Neuroblastomas vary widely in their sensitivities to herpes simplex virotherapy unrelated to virus receptors and susceptibility.

  • Authors : Wang PY; Center for Childhood Cancer and Blood Diseases, The Research Institute at Nationwide Children's Hospital, Columbus, OH, USA.; Swain HM

Subjects: Herpesvirus 1, Human*/Herpesvirus 1, Human*/Herpesvirus 1, Human*/genetics ; Herpesvirus 1, Human*/Herpesvirus 1, Human*/Herpesvirus 1, Human*/metabolism ; Oncolytic Virotherapy*

  • Source: Gene therapy [Gene Ther] 2016 Feb; Vol. 23 (2), pp. 135-43. Date of Electronic Publication: 2015 Nov 19.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
Academic Journal

Gene therapy progress and prospects cancer: oncolytic viruses.

  • Authors : Liu TC; Department of Clinical Research, Jennerex Biotherapeutics Inc., San Francisco, CA, USA.; Kirn D

Subjects: Genetic Therapy/Genetic Therapy/Genetic Therapy/*methods ; Neoplasms/Neoplasms/Neoplasms/*therapy ; Oncolytic Virotherapy/Oncolytic Virotherapy/Oncolytic Virotherapy/*methods

  • Source: Gene therapy [Gene Ther] 2008 Jun; Vol. 15 (12), pp. 877-84. Date of Electronic Publication: 2008 Apr 17.Publisher: Nature Publishing Group Country of Publication: England NLM ID: 9421525 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

×
  • 1-10 of  695 results for ""Oncolytic Viruses""